MAIA Biotechnology, a US-listed company, launches a crypto-treasury strategy

PANews reported on October 7 that according to Globenewswire, MAIA Biotechnology, listed on NYSE American under the New York Stock Exchange, announced the official launch of its crypto treasury strategy. At the same time, its board of directors has approved investing 90% of the company's liquid assets in leading cryptocurrencies. The initial investment will purchase BTC, ETH and USDC. It is reported that the company will also establish a digital asset advisory committee to provide support for related purchase transactions.

Share to:

Author: PA一线

This content is for informational purposes only and does not constitute investment advice.

Follow PANews official accounts, navigate bull and bear markets together
Recommended Reading
3 minute ago
20 minute ago
3 hour ago
4 hour ago
5 hour ago
15 hour ago

Popular Articles

Industry News
Market Trends
Curated Readings

Curated Series

App内阅读